Codice QR

Prospective randomized evaluation of ciprofloxacin versus piperacillin plus amikacin for empiric antibiotic therapy of febrile granulocytopenic cancer patients with lymphomas and solid tumors. The European Organization for Research on Treatment of Cancer International Antimicrobial Therapy Cooperative Group.

Empiric therapy for febrile granulocytopenic patients is mandatory, but whether monotherapy is a safe alternative and whether fluoroquinolones are useful agents for this indication are still controversial issues. The use of monotherapy with intravenous ciprofloxacin (200 to 300 mg every 12 h) was ev...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Antimicrob Agents Chemother
Autori principali: Meunier, F, Zinner, S H, Gaya, H, Calandra, T, Viscoli, C, Klastersky, J, Glauser, M
Natura: Artigo
Lingua:Inglês
Pubblicazione: American Society for Microbiology (ASM) 1991
Soggetti:
Accesso online:https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC245122/
https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/1854169/
https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.35.5.873
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne!!